Silver Book

Silver Book Fact

Patients with vertebral fractures who underwent kyphoplasty, a procedure that stabilizes fractures of the spine, were found in one study to have reduced pain, fewer new fractures, and less healthcare utilization for at least 12 months.

Grafe, Ingo A., Katharina Da Fronseca, Jochen Hillmeier, Peter-Jürgen Meeder, Martin Libicher, Gerd Nöldge, Hubert Bardenheuer, Walter Pyerin, Linus Basler, Christel Weiss, Rod S. Taylor, Peter Nawroth, and Christian Kasperk. Reduction of Pain and Fracture Incidence After Kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis. Osteoporos Int. 2005; 16(12): 2005-12. http://www.springerlink.com/content/q235u1m804u08551/?p=34936217d13e479297297d5ff7202c45&pi=72

Reference

Title
Reduction of Pain and Fracture Incidence After Kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis
Publication
Osteoporos Int
Publication Date
2005
Authors
Grafe, Ingo A., Katharina Da Fronseca, Jochen Hillmeier, Peter-Jürgen Meeder, Martin Libicher, Gerd Nöldge, Hubert Bardenheuer, Walter Pyerin, Linus Basler, Christel Weiss, Rod S. Taylor, Peter Nawroth, and Christian Kasperk
Volume & Issue
Volume 16, Issue 12
Pages
2005-12
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A study that looked at a combination of calcium and Vitamin D found that hip fractures were reduced by around 43%.  
  • An increase in bone mineral density (BMD) testing and osteoporosis treatment was associated with a decrease in hip fracture incidence.  
  • Risedronate, a bisphosphonate, has been shown to increase vertebral bone mineral density (BMD) by around 5% and hip BMD by 2% to 3% in postmenopausal women with osteoporosis.  
  • A systematic review of osteoporosis therapies found good evidence that many are effective in preventing fractures, but concluded that the data are insufficient to determine if any one therapy is…  
  • Randomized controlled trials give evidence that pharmacologic therapy can reduce risk of fractures by 40 to 50%.